Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report

Abstract

Background

This study aimed to improve the understanding of acute myeloid leukemia (AML) secondary to chronic lymphocytic leukemia (CLL), and to explore the sequence of occurrence and clonal origin of the two diseases.

Case Report

We reported a case of a 71-year-old man with a history of CLL. The patient was administrated with chlorambucil for 19 years and was admitted to our hospital due to fever. Then he was subjected with routine blood tests, bone marrow smear examination, flow cytometric immunophenotyping and cytogenetic analysis. A final diagnosis of AML-M2 secondary to CLL with -Y,del(4q),del(5q),-7,add(12p),der(17),der(18),-22,+mar was made. After rejecting the therapy with Azacitidine combined with B-cell lymphoma-2 (Bcl-2) inhibitor, the patient died of pulmonary infection.

Conclusion

This case highlights the rare occurrence of AML secondary to CLL after prolonged chlorambucil therapy and the poor prognosis of such cases, underscoring the importance of enhanced assessment of these patients.

Keywords:

• acute myeloid leukemia
• chronic lymphocytic leukemia
• Bcl-2 inhibitor
• Azacitidine

Data Sharing Statement

All relevant data and materials are included in the article.

Statement of Ethics

This study was approved by the ethics committee of the Harison International Peace Hospital Affiliated to Hebei Medical University. This study followed the principles of the Declaration of Helsinki, and informed consent was obtained from the patient’s family for publication of this case report and any accompanying images.

Disclosure

The authors report no conflicts of interest in this work.